参考文献/References:
[1] 崔京远, 马 红, 马文慧,等. 结肠癌组织中Cyr61和HPA-1的表达水平及其在侵袭转移中的作用[J]. 中国现代普通外科进展, 2012, 15(6):439-443.
[2] Tsao CW, Tang CH, Chuang JY. Abstract 4: WISP-1 increases angiogenesis and VEGF-A expression in human oral squamous cell carcinomas[J]. Cancer Research, 2014, 74(19):4-4.
[3] Tong X, Xie D, O'Kelly J,et al. Cyr61, a member of CCN family, is a tumor suppressor in Non-small cell lung cancer[J]. Journal of Biological Chemistry, 2001, 276(50):47709-47714.
[4] Menendez J, Vellon L, Mehmi I, et al. A novel CYR61-triggered CYR61-alphavbeta3 integrin loop regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway[J]. Oncogene, 2005, 24(5):761-779.
[5] 唐琼兰, 李海刚, 沈溪明,等. Cyr61在结肠癌血管生成中的作用及临床意义[J]. 岭南现代临床外科, 2010, 10(4):245-248.
[6] 张晓君, 李建生, 李珍杰,等. Cyr61、VEGF在结肠癌中的表达及临床意义[J]. 临床消化病杂志, 2008, 20(4):227-229.
[7] Sampath D, Winneker RC, Zhang Z. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer[J]. Endocrinology, 2001, 142(6):2540-2548.
[8] Maeta N, Osaki M, Shomori K, et al. CYR61 Downregulation Correlates with Tumor Progression by Promoting MMP-7 Expression in Human Gastric Carcinoma[J]. Oncology, 2007, 73(1-2):118-126.
[9] Huang X, Xiao D, Xu L, et al. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma[J]. Oncology Reports, 2009, 21(4):1123-1123.
[10] Xie J, Xu L, Xie Y, et al. Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells[J]. International Journal of Molecular Medicine, 2011, 27(3):429-434.
[11] Tang Q, Fan S, Li H, et al. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis[J]. Oral Oncology, 2011, 47(47):365-370.
[12] Shi W, Yin J, Chen Z, et al. Cyr61 promotes growth of pancreatic carcinoma via nuclear exclusion of p27[J]. Tumor Biology, 2014, 35(11):11147-11147.
[13] Komatsu D, Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair[J]. Bone, 2004, 34(4):680-688.
[14] 张曼曼, 王 恒, 赵 逵. Cyr61与结肠癌发生发展的关系[J]. 山东医药, 2013, 53(20):95-96.
[15] Radke S, Battmann A, Jatzke S, et al. Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head[J]. Journal of Orthopaedic Research, 2006, 24(5):945-952.
[16] Athanasopoulos A, Schneider D, Keiper T,et al. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 inosteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing[J].Journal of Biological Chemistry, 2007, 282(37):26746-26753.
[17] 王丽萍, 吴金河, 刘爱东,等. Cyr61和MMP-9在胃癌中的表达及临床意义[J]. 中国误诊学杂志, 2011, 11(21):5074-5075.
相似文献/References:
[1]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[2]何洪标,梁俏敏,郑曙光.结直肠锯齿状息肉病相关通道蛋白表达水平对患者病情的影响*[J].陕西医学杂志,2020,49(6):679.[doi:DOI:10.3969/j.issn.10007377.2020.06.010]
HE Hongbiao,LIANG Qiaomin,ZHEGN Shuguang..Effect of colorectal serrated polyposis related channel protein expression level on patients' condition[J].,2020,49(4):679.[doi:DOI:10.3969/j.issn.10007377.2020.06.010]
[3]裴彦江,戚 斌.术前替吉奥联合奥沙利铂新辅助化疗治疗SiewertⅡ型食管胃结合部腺癌临床疗效研究[J].陕西医学杂志,2022,51(11):1420.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.024]
[4]王镜纯,吴 宝,白玉勤.肺腺癌组织细胞分裂周期相关蛋白8蛋白表达及与临床病理参数、预后关系分析[J].陕西医学杂志,2023,52(10):1427.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.033]
WANG Jingchun,WU Bao,BAI Yuqin.Expression of CDCA8 protein in lung adenocarcinoma tissue and its relationship with clinicopathologic parameters and the prognosis[J].,2023,52(4):1427.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.033]